date,title,source
Oct-18-18,Watertown biotech Selecta halts cancer drug trial after patient dies,American City Business Journals
Oct-23-18,"Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018",GlobeNewswire
